Skip to main content

ORIGINAL RESEARCH article

Front. Gastroenterol.

Sec. Hepatology

Volume 4 - 2025 | doi: 10.3389/fgstr.2025.1534145

This article is part of the Research Topic The Multifaceted Role of Cholangiocytes in Neoplastic and Non-Neoplastic Cholangiopathies: From Bench to Bedside View all articles

Risk Factors for Mortality in Patients with Primary Biliary Cholangitis: A Nomogram to Predict 5-Year Survival

Provisionally accepted
Muyu Gao Muyu Gao 1Yaxing Liu Yaxing Liu 2Bin Li Bin Li 2Long Liu Long Liu 2Yao Liu Yao Liu 2Ying Feng Ying Feng 2Xiaojing Wang Xiaojing Wang 2Xianbo Wang Xianbo Wang 2Guiqin Zhou Guiqin Zhou 2*
  • 1 Beijing University of Chinese Medicine, Beijing, China
  • 2 Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

    The issue of transplant-free survival rate (OS) among patients with primary biliary cholangitis (PBC) remains a persistent concern. In predicting the long-term OS of PBC patients, given the complexity and population specificity of models such as the GLOBE and UK-PBC, our objective is to calculate and assess the risk factors for mortality and 5-year OS among PBC patients based on routine clinical data,ultimately facilitating its clinical application.This study enrolled 315 patients with PBC from Beijing Ditan Hospital and randomly divided them into a training cohort (n = 189) and a validation cohort (n = 126). Through Cox regression analyses, we identified risk predictors of mortality to develop a 5-year survival nomogram for PBC. The model was evaluated with Receiver Operating Characteristic (ROC) curves, calibration curves, Decision Curve Analysis (DCA).Kaplan-Meier (KM) curves compared OS across risk groups. Additionally, correlations among the indicators were analyzed. Results Ultimately, we established a nomogram incorporating Age, NLR, and TBIL. The Area Under the ROC Curve(AUC-ROC) values for the training and validation groups were 0.7251 and 0.7721, respectively, indicating solid consistency and outperforming the GLOBE model. Calibration and DCA curves further underscored the clinical utility of our model.KM curves revealed the model could differentiate OS across risk levels in subgroup.Additionally, a significant correlation between NLR and TBIL (P=0.0021) was observed, potentially impacting patient prognosis. Conclusion We have constructed a well-performing prognostic model based on Age, NLR, and TBIL. This model shows good discrimination, consistency, and clinical use.It helps identifying high-risk patients, enabling more frequent follow-ups and tailored interventions, potentially enhancing prognosis and clinical outcomes.

    Keywords: Primary biliary cholangitis, age, Bilirubin, Neutrophil to lymphocyte ratio, Risks factor

    Received: 25 Nov 2024; Accepted: 20 Feb 2025.

    Copyright: © 2025 Gao, Liu, Li, Liu, Liu, Feng, Wang, Wang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guiqin Zhou, Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing Municipality, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more